BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17715258)

  • 1. The role of intention to treat in analysis of noninferiority studies.
    Wiens BL; Zhao W
    Clin Trials; 2007; 4(3):286-91. PubMed ID: 17715258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.
    Kim MY
    J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian inference for randomized clinical trials with treatment failures.
    Shaffer ML; Chinchilli VM
    Stat Med; 2004 Apr; 23(8):1215-28. PubMed ID: 15083479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S; Diamond GA
    Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for interaction in studies of noninferiority.
    Wiens BL; Heyse JF
    J Biopharm Stat; 2003 Feb; 13(1):103-15. PubMed ID: 12635906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for randomized controlled trials and for intention-to-treat analysis in transfusion medicine: are they one and the same?
    Vamvakas EC
    Vox Sang; 2008 Oct; 95(3):165-73. PubMed ID: 19121180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of randomized controlled trials.
    Stanley K
    Circulation; 2007 Apr; 115(13):1819-22. PubMed ID: 17404173
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of the intention-to-treat principle in nursing clinical trials.
    Polit DF; Gillespie BM
    Nurs Res; 2009; 58(6):391-9. PubMed ID: 19918150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian sensitivity model for intention-to-treat analysis on binary outcomes with dropouts.
    Kaciroti NA; Schork MA; Raghunathan T; Julius S
    Stat Med; 2009 Feb; 28(4):572-85. PubMed ID: 19072769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.
    Bamat NA; Ekhaguere OA; Zhang L; Flannery DD; Handley SC; Herrick HM; Ellenberg SS
    Clin Trials; 2020 Oct; 17(5):552-559. PubMed ID: 32666826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial design for assessing noninferiority when superiority is expected.
    Freidlin B; Korn EL; George SL; Gray R
    J Clin Oncol; 2007 Nov; 25(31):5019-23. PubMed ID: 17971602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo cluster randomization: a treatment allocation method to minimize contamination and selection bias.
    Borm GF; Melis RJ; Teerenstra S; Peer PG
    Stat Med; 2005 Dec; 24(23):3535-47. PubMed ID: 16007575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninferiority testing in crossover trials with correlated binary outcomes and small event proportions with applications to the analysis of condom failure data.
    Taylor DJ; Dominik RC
    J Biopharm Stat; 1999 May; 9(2):365-77. PubMed ID: 10379699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.